Estradiol  - novelty or standard in vaginal therapy?

Edyta Wlaźlak; Grzegorz Surkont; Jacek Suzin

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

5/2004
vol. 3

Send email

Copy url:

abstract:

Estradiol - novelty or standard in vaginal therapy?

Edyta Wlaźlak

,

Grzegorz Surkont

,

Jacek Suzin

Online publish date: 2004/10/22

View full text Get citation

Authors present review of articles about the use of vaginal tablets containing 25 µg of 17β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 µg of 17β-estradiol does not have clinically significant systemic activity. Till now, if properly used, vaginal tablet containing 25 µg of 17β-estradiol does not show stimulating activity on endometrium. Authors consider that medicaments containing estradiol ad estriol are both standards in modern vaginal estrogen therapy. Vaginal tablet containing 17β-estradiol are noticed by most of the patients as more comfortable ad hygienic than vagitories and creams.

keywords:

Estradiol - novelty or standard in vaginal therapy?

Edyta Wlaźlak , Grzegorz Surkont , Jacek Suzin

vaginal estrogen therapy, menopause, urinary incontinence, atrophic vaginitis

Edyta Wlaźlak

,

Grzegorz Surkont

,

Jacek Suzin